Focused therapeutics for oncology
Founded in 2002, we are a clinical stage biotech company committed to the discovery and development of novel and effective therapeutics for the treatment of cancer.
We leverage our deep expertise in oncology focused novel therapeutics for the benefit of cancer patients everywhere.
Founded in 2002, we are a clinical stage biotech company committed to the discovery and development of novel and effective therapeutics for the treatment of cancer.
We leverage our deep expertise in oncology focused novel therapeutics for the benefit of cancer patients everywhere.
We focus on developing innovative therapeutics addressing several hallmarks of cancer, leveraging our deep capabilities in science and building value added collaborations with leading companies globally.
We have built comprehensive drug discovery and development capabilities, nurtured a growing team of passionate scientists, and collaborated with partners from across the world.
Two decades of drug discovery and development experience
integrated drug discovery projects
programs in global clinical development
scientists
NCE patents
Get the latest updates from Aurigene in the news, conferences, events, and more.